The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ALKERMES PLC | SHS | G01767105 | 44,081 | 937,300 | SH | SOLE | 937,300 | 0 | 0 | ||
AMAG PHARMACEUTICALS | COM | 00163U106 | 14,985 | 611,390 | SH | SOLE | 611,390 | 0 | 0 | ||
ARENA PHARMACEUTICALS INC | COM | 040047102 | 18,375 | 10,500,000 | SH | SOLE | 10,500,000 | 0 | 0 | ||
BIOLASE INC | WARRANTS | 909911108 | 5 | 1,841,173 | SH | Call | SOLE | 1,841,173 | 0 | 0 | |
BIOLASE INC | COM | 909911108 | 9,332 | 5,332,394 | SH | SOLE | 5,332,394 | 0 | 0 | ||
BIOSCRIP INC | COM | 09069N108 | 29,420 | 10,180,000 | SH | SOLE | 10,180,000 | 0 | 0 | ||
BROOKDALE SENIOR LIVING | COM | 112463104 | 69,800 | 4,000,000 | SH | SOLE | 4,000,000 | 0 | 0 | ||
CARDIOVASCULAR SYSTEMS INC | COM | 141619106 | 71,220 | 3,000,000 | SH | SOLE | 3,000,000 | 0 | 0 | ||
CATABASIS PHARMACEUTICALS INC | COM | 14875P107 | 6,160 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
TARGACEPT INC | NOTE | 87611RAA6 | 1,685 | 1,684,799 | PRN | SOLE | 1,684,799 | 0 | 0 | ||
COMMUNITY HEALTH SYS INC NE COM | COM | 203668108 | 57,700 | 5,000,000 | SH | SOLE | 5,000,000 | 0 | 0 | ||
CONMED CORP COM | COM | 207410101 | 30,045 | 750,000 | SH | SOLE | 750,000 | 0 | 0 | ||
DEXTERA SURGICAL INC. | COM | 252366109 | 1,583 | 837,483 | SH | SOLE | 837,483 | 0 | 0 | ||
ENDO INT PLC | SHS | G30401106 | 85,436 | 4,240,000 | SH | SOLE | 4,240,000 | 0 | 0 | ||
ENDOLOGIX INC | COM | 29266S106 | 12,800 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
GENOMIC HEALTH INC | COM | 37244C101 | 71,088 | 2,458,100 | SH | SOLE | 2,458,100 | 0 | 0 | ||
GILEAD SCIENCES, INC. | COM | 375558103 | 79,120 | 1,000,000 | SH | Call | SOLE | 1,000,000 | 0 | 0 | |
GILEAD SCIENCES, INC. | COM | 375558103 | 94,944 | 1,200,000 | SH | SOLE | 1,200,000 | 0 | 0 | ||
INNOCOLL AG | COM | 47580Q103 | 6,228 | 1,059,139 | SH | SOLE | 1,059,139 | 0 | 0 | ||
INVITAE CORP | COM | 46185L103 | 21,393 | 2,442,122 | SH | SOLE | 2,442,122 | 0 | 0 | ||
LIVANOVA PLC | SHS | G5509L101 | 60,110 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
MEDICINES COMPANY | COM | 584688105 | 75,480 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
MYLAN NV | SHS EURO | N59465109 | 147,639 | 3,873,000 | SH | SOLE | 3,873,000 | 0 | 0 | ||
NEKTAR THERAPEUTICS | COM | 640268108 | 54,976 | 3,200,000 | SH | SOLE | 3,200,000 | 0 | 0 | ||
ORTHOFIX INTL N V | COM | N6748L102 | 64,155 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
PERRIGO COMPANY | SHS | G97822103 | 112,052 | 1,213,600 | SH | SOLE | 1,213,600 | 0 | 0 | ||
PROTALIX BIO THERAPEUTICS, INC | NOTE 4.500% 9/1 | 74365AAB7 | 5,642 | 9,000,000 | PRN | SOLE | 9,000,000 | 0 | 0 | ||
PROTALIX BIO THERAPEUTICS, INC | COM | 74365A101 | 7,434 | 13,275,000 | SH | SOLE | 13,275,000 | 0 | 0 | ||
PTC THERAPEUTICS | COM | 69366J200 | 28,020 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
SELECT MEDICAL HOLDINGS CORP | COM | 81619Q105 | 81,338 | 6,025,000 | SH | SOLE | 6,025,000 | 0 | 0 | ||
SPDR S&P 500 ETF Trust | COM | 78462F103 | 486,675 | 2,250,000 | SH | Put | SOLE | 2,250,000 | 0 | 0 | |
SYNERON MEDICAL LTD | ORD SHS | M87245102 | 16,809 | 2,347,593 | SH | SOLE | 2,347,593 | 0 | 0 | ||
TENET HEALTHCARE CORP THC | COM NEW | 88033G100 | 56,650 | 2,500,000 | SH | SOLE | 2,500,000 | 0 | 0 | ||
TEVA PHARMACEUTICAL INDUSTRIES LTD (ADR) | ADR | 881624209 | 92,020 | 2,000,000 | SH | Call | SOLE | 2,000,000 | 0 | 0 | |
TEVA PHARMACEUTICAL INDUSTRIES LTD (ADR) | ADR | 881624209 | 184,040 | 4,000,000 | SH | SOLE | 4,000,000 | 0 | 0 | ||
UNIVERSAL AMERICAN CORPORATION | COM | 91338E101 | 44,944 | 5,875,000 | SH | SOLE | 5,875,000 | 0 | 0 | ||
VALEANT PHARMACEUTICALS INT (USA) | COM | 91911K102 | 31,215 | 1,271,500 | SH | SOLE | 1,271,500 | 0 | 0 |